🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the value of bortezomib in combination with specified ...
Status
Completed
Location
Stanford University, School of Medicine
Start Date
2013-03
Trial ID
NCT01769209
This phase II trial studies how well vosaroxin and cytarabine work in treat...
Status
Completed
Location
Yale University
Start Date
2016-03
Trial ID
NCT02658487
Treatments Being Tested
This phase I trial studies the side effects and best dose of wee1 kinase in...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-05-25
Trial ID
NCT02791919
This phase III trial compares the effect of usual treatment of chemotherapy...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2021-01-25
Trial ID
NCT04530565
Treatments Being Tested
This clinical trial is for men and women with whose lymphoma (non-Hodgkin o...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2014-06-04
Trial ID
NCT02059239
The goal of this clinical research study is to learn if intensive chemother...
Status
Completed
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2002-08
Trial ID
NCT00669877
Treatments Being Tested
This phase I trial studies the side effects and determine the best dose of ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2016-05-04
Trial ID
NCT02649764
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as cytarabine and daunorubicin,...
Status
Completed
Location
Providence Cancer Center
Start Date
2004-07
Trial ID
NCT00085709
Treatments Being Tested
This phase I/II trial finds the best dose, side effects and how well giving...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2022-02-04
Trial ID
NCT04797767
This study is a multicenter, prospective, randomized, controlled clinical t...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2024-11-18
Trial ID
NCT07514936